XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.810
-0.130 (-6.70%)
Oct 22, 2024, 4:00 PM EDT - Market closed
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $24.35 million as of October 23, 2024. Its market cap has increased by 368.28% in one year.
Market Cap
24.35M
Enterprise Value
22.06M
1-Year Change
368.28%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since November 18, 2008, XTL Biopharmaceuticals's market cap has increased from $800.00K to $24.35M, an increase of 2,943.83%. That is a compound annual growth rate of 23.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 9.90M | 80.00% |
| Dec 29, 2023 | 5.50M | -16.67% |
| Dec 30, 2022 | 6.60M | -53.52% |
| Dec 31, 2021 | 14.20M | -8.97% |
| Dec 31, 2020 | 15.60M | 122.86% |
| Dec 31, 2019 | 7.00M | -21.35% |
| Dec 31, 2018 | 8.90M | 41.27% |
| Dec 29, 2017 | 6.30M | 270.59% |
| Dec 30, 2016 | 1.70M | -56.41% |
| Dec 31, 2015 | 3.90M | -15.22% |
| Dec 31, 2014 | 4.60M | -31.34% |
| Dec 31, 2013 | 6.70M | -55.63% |
| Dec 31, 2012 | 15.10M | 106.85% |
| Dec 30, 2011 | 7.30M | 160.71% |
| Dec 31, 2010 | 2.80M | 366.67% |
| Dec 31, 2009 | 600.00K | 100.00% |
| Dec 31, 2008 | 300.00K | -62.50% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 28.90M |
| Femasys | 28.90M |
| Bionano Genomics | 28.66M |
| NeuroOne Medical Technologies | 28.22M |
| Lipocine | 27.97M |
| The Oncology Institute | 27.93M |
| SAB Biotherapeutics | 27.78M |
| Tempest Therapeutics | 27.73M |